ASAM declared its support for The Recovery Enhancement for Addiction Treatment (TREAT) Act. This bill would lift the buprenorphine prescribing limit for addiction physician specialists and non-specialist providers. As it stands, the prescribing limit inhibits treatment for many people suffering from the chronic disease of addiction.

Read the ASAM letter of support from Dr. Gitlow.

Author: adweb.admin

Nick Covanes is the C.E.O. and Creative Director of Adwebvertising, LLC and has been a leader in the industry since 2011. Nick is experienced in all facets of digital marketing and provides this experience to individual businesses and organizations to help them realize their full growth potential.